Extending Life with Hyperbaric Oxygen Therapy

Who Benefits?Schedule an Appointment

Extending Life with Hyperbaric Oxygen Therapy

Who Benefits?Schedule an Appointment

Personalized Treatments

Unique treatment plans created for patients suffering from a variety of conditions

Scientifically Proven

Used in hospitals and clinics around the world

HBOT Treatments

Reduce inflammation and enhance the body’s natural ability to heal

Professional Team

An experienced team of medical doctors and staff dedicated to your well-being

EXPLORING HBOT RESEARCH

Recent HBOT Research

Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen Therapy

Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen Therapy

Returning veterans are frequently diagnosed with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Considering a recent case-controlled study of hyperbaric oxygen therapy (HBOT) reporting a reduction in suicidal ideation, we investigated retrospectively three veterans with chronic TBI/PTSD symptoms who were treated with multiple rounds of HBOT with neurophysiological testing performed before and after treatment. Improvements were detected on parameters within neurocognitive domains, including reductions in suicide-related symptoms. These findings independently confirm that HBOT may be effective in treating specific symptoms of TBI/PTSD that are not currently addressed with existing therapeutic approaches.

The National Brain Injury Rescue and Rehabilitation Study – a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms

The National Brain Injury Rescue and Rehabilitation Study – a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms

The National Brain Injury Rescue and Rehabilitation Project was established as a preliminary study to test the safety and practicality of multi-center hyperbaric oxygen administration for the post-concussive symptoms of chronic mild traumatic brain injury as a precursor to a pivotal, independent, multi-center, controlled clinical trial. This report presents the results for 32 subjects who completed a preliminary trial of hyperbaric oxygen several years before the passage of the 21 st Century Cures Act. This study anticipated the Act and its reassessment of clinical research. Subjects received 40-82 one-hour treatments at 1.5 atmospheres absolute 100% oxygen. Outcome measures included repeated self-assessment measures and automated neurocognitive tests. The subjects demonstrated improvement in 21 of 25 neurocognitive test measures observed. The objective neurocognitive test components showed improvement in 13 of 17 measures. Earlier administration of hyperbaric oxygen post injury, younger age at the time of injury and hyperbaric oxygen administration, military status, and increased number of hyperbaric oxygen administrations were characteristics associated with improved outcomes. There were no adverse events. Hyperbaric oxygen was found to be safe, inexpensive and worthy of clinical application in the 21 st Century model of facile data collection provided by recent research regulatory shifts in medicine. The study was approved by the ethics review committee of the Western Institutional Review Board (WIRB; Protocol #20090761).

Noninvasive Therapy that can help in a variety of medical conditions

Noninvasive Therapy that can help in a variety of medical conditions

Benefits of Hyperbaric Oxygen Therapy

Improves Circulation

Maximizes Oxygen Transport

Preserves, Repairs, & Enhances Cellular Functions

Increases Amount of Oxygen in the Blood

Accelerates Wound Healing

Prevents Further Cellular Damage

Reduces Inflammation & Swelling

Enhances Anti-Microbial Function

ABOUT OUR CLINIC

WE ARE MULTI-SEAT HYPERBARIC CHAMBER CLINIC

A multi-seat hyperbaric chamber is designed to treat multiple patients at a time. Patients sit in chairs while they receive oxygen through individual hoods while the chamber pressurizes to equivalent pressure of a shallow dive.

Recent HBOT News

The Nobel Prize in Physiology or Medicine 2019 – Sensing oxygen levels

The Nobel Prize in Physiology or Medicine 2019 – Sensing oxygen levels

The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.